HT mAb Production

HT Production and Purification Process


  • Cost-effective production of large number (50-100) of monoclonal antibodies from supplied antibody sequences.
  • Optimized expression vectors and transient trasfection procedure that provides robust and veratile production of up to 500 mg/L recombinant antibodies.
  • Purified antibodies are suitable for biological assay thanks to very low endotoxin content (<0.1EU/mg).
  • Several QC available upon request (SDS-PAGE, SEC-HPLC, ELISA, Flow cytometry, endotoxin level)

Follow Us on Linkedin

Takis is a biotech dedicated to cancer research. Our primary objective is the development of innovative therapies based on the principle that our immune system can be “instructed” to recognize the tumor and reject it as a foreign entity.